The Usual Late ESU Manipulation Saved The Session

The King Report for September 11, 2019 Tuesday’s report was briefer than usual because there was a lack of impact news; equity market action was... The post The Usual Late ESU Manipulation Saved The Session appeared first on ValueWalk......»»

Category: blogSource: valuewalkSep 11th, 2019

Dow retakes perch at 27,000 as blue-chip index attempts to stretch gains to 6th session

The Dow Jones Industrial Average late-morning Wednesday was extending a multiday climb that has pushed it above the psychologically significant of 27,000 for the first time in weeks. Th.....»»

Category: topSource: marketwatchSep 11th, 2019

Late Rally Stretches Dow Winning Streak to 5 Days

Late Rally Stretches Dow Winning Streak to 5 Days SPECIAL ALERT: The September episode of the Zacks Ultimate Strategy Session is now available for viewing! Tune in to this “must-see” event when Kevin Matras, .....»»

Category: smallbizSource: nytSep 11th, 2019

Dow notches 5th straight gain, marks longest win streak in 3 months; small-caps outperform

U.S. stock benchmarks closed mostly higher Tuesday, delivering a late-session jolt higher, backed by gains in energy and materials as bond yields jumped. Meanwhile, small-capitalization stocks delivered a marked outperformance agai.....»»

Category: topSource: marketwatchSep 10th, 2019

Stocks Have Mixed Day As UK Political Uncertainty Weighs On Markets

 Commenting on today’s trading Gorilla Trades strategist Ken Berman said:  Although stocks were under pressure most of the day, the late-session bounce could mean that last week’s rally will soon resume.....»»

Category: blogSource: valuewalkSep 3rd, 2019

Dow wipes out 187-point gain to turn negative in Thursday morning action amid hawkish Fed speakers, weak data

U.S. stocks stumbled to session lows late-morning Thursday, relinquishing earlier gains on the day amid a pair of central bank speakers at a closely watched symposium in Jackson Hole, Wyo., and weak manufacturing data. The Dow Jones Industrial Average wa.....»»

Category: topSource: marketwatchAug 22nd, 2019

European shares gain for third straight session, AstraZeneca boosts

European shares rose for the third straight session on Tuesday, building on a recovery since late last week as British drugmaker AstraZeneca gained on positive data from a late-stage study. Francis Maguire reports......»»

Category: videoSource: reutersAug 20th, 2019

Arista Networks stock swings to loss following earnings beat

Arista Networks Inc. shares swung to a loss in the extended session Thursday after the cloud-networking company forecast weaker-than-usual growth in the second half after quarterly results topped Wall Street expectations. Ari.....»»

Category: topSource: marketwatchAug 1st, 2019

Yum China beats Q2 expectations but sees "moderate" growth ahead

Yum China Holdings Inc. late Tuesday reported second-quarter earnings and sales that beat expectations, but shares were flat in the extended session as the company said it expect.....»»

Category: topSource: marketwatchJul 30th, 2019

Ed Goldman: Mike Oliver wants women to feel "Safe In The City"

Mike Oliver named his women’s self-defense program “Safe in the City” for how he wants women to feel — whether they’re walking down dark streets late at night or facing brutality in the well-lighted privacy of their own homes. A new session o.....»»

Category: topSource: bizjournalsJul 30th, 2019

Oil rises near $64/bbl on second downed Iranian drone

Oil rose to almost $64 on Tuesday, jumping late in the session after the head of U.S. Central Command said the United States may have taken down a second Iranian drone over the Strait of Hormuz last week......»»

Category: topSource: reutersJul 23rd, 2019

Rate Cut Hopes End Market’s Two-Day Slide

Rate Cut Hopes End Market’s Two-Day Slide With a little help from a top Fed official, the major indices staged a late-session rally on Thursday to finish.....»»

Category: smallbizSource: nytJul 19th, 2019

In The Thick Of It: Bank Results Highlight Morning, With NFLX At Center Screen Late

Today’s session starts with banks and ends with a FAANG. Bank of America Corp (NYSE: BAC) and seve.....»»

Category: earningsSource: benzingaJul 17th, 2019

S&P 500 falls for fourth straight session

Technology stocks were a standout after a late-day sell-off pushed the rest of the market into negative territory as trade hopes fizzled. Conway G. Gittens reports......»»

Category: videoSource: reutersJun 26th, 2019

Legislature adjourns after a flurry of late bills

The "big ugly" package of last-minute bills is a June tradition in Albany. But this year the legislative session dribbled out a succession of "little uglies" that are certain to buffet the business... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJun 24th, 2019

The Margin: Trump just ‘liked’ a tweet for the first time in two years — but why this one?

Trump apparently had love on the brain during his latest late-night Twitter session. Or at least “like.”.....»»

Category: topSource: marketwatchJun 12th, 2019

Gold futures up a 5th session, longest streak of gains since late January

Gold futures climbed a fifth session in a row on Tuesday, the longest streak of gains in more than four months. A broad rise in benchmark U.S. stock indexes failed to knock prices for the haven metal lower, as gold has climbed this week.....»»

Category: topSource: marketwatchJun 4th, 2019

Tesla stock nears a three-year low

Tesla Inc. shares fell more than 4% in late trading Monday, poised to close at their lowest since February 2016 and extending their losing streak to a third session. Tesla has been under pressure from Wall Street on concerns about demand fo.....»»

Category: topSource: marketwatchJun 3rd, 2019

Gold up a fourth session in a row, settles at highest since late February

Gold futures climbed a fourth session in a row on Monday to .....»»

Category: topSource: marketwatchJun 3rd, 2019

Amarin shares soar after FDA agrees to review fish oil pill for heart patients

The FDA plans to review Vascep within six months instead of the usual 10, with a decision on approval expected sometime in late September......»»

Category: topSource: moneycentralMay 29th, 2019

Why BioCryst’s HAE Treatment Failed to Impress

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients......»»

Category: blogSource: 247wallstMay 21st, 2019